LEVOTHOX levothyroxine sodium 100 microgram tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

levothox levothyroxine sodium 100 microgram tablet bottle

accord healthcare pty ltd - levothyroxine sodium, quantity: 100 microgram - tablet, uncoated - excipient ingredients: sodium starch glycollate; light magnesium oxide; microcrystalline cellulose; sodium stearylfumarate; sunset yellow fcf aluminium lake; tartrazine aluminium lake - levothox is indicated for the management of demonstrated thyroid hormone deficiency.,levothox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

LEVOTHOX levothyroxine sodium 75 microgram tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

levothox levothyroxine sodium 75 microgram tablet bottle

accord healthcare pty ltd - levothyroxine sodium, quantity: 75 microgram - tablet, uncoated - excipient ingredients: light magnesium oxide; sodium stearylfumarate; sodium starch glycollate; microcrystalline cellulose; allura red ac aluminium lake; indigo carmine aluminium lake - levothox is indicated for the management of demonstrated thyroid hormone deficiency.,levothox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

APO-LEVOTHYROXINE levothyroxine sodium 200 microgram un-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-levothyroxine levothyroxine sodium 200 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

LEVOTHYROXINE LUP levothyroxine sodium 200 microgram un-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

levothyroxine lup levothyroxine sodium 200 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

APO-LEVOTHYROXINE levothyroxine sodium 150 microgram un-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-levothyroxine levothyroxine sodium 150 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.15 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

LEVOTHYROXINE LUP levothyroxine sodium 150 microgram un-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

levothyroxine lup levothyroxine sodium 150 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.15 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

APO-LEVOTHYROXINE levothyroxine sodium 125 microgram un-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-levothyroxine levothyroxine sodium 125 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.125 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

LEVOTHYROXINE LUP levothyroxine sodium 125 microgram un-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

levothyroxine lup levothyroxine sodium 125 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.125 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

APO-LEVOTHYROXINE levothyroxine sodium 100 microgram un-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-levothyroxine levothyroxine sodium 100 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.1 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

LEVOTHYROXINE LUP levothyroxine sodium 100 microgram un-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

levothyroxine lup levothyroxine sodium 100 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.1 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.